PDS Biotechnology Corporation logo
PDS Biotechnology Corporation PDSB
$ 5.91 -5.29%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

PDS Biotechnology Corporation Financial Ratios 2011-2024 | PDSB

Annual Financial Ratios PDS Biotechnology Corporation

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-16.8 -8.7 -24.2 -3.2 -1.8 -0.3 -7.6 -7.2 -3.2 - - - -

P/S

- - - - - - - - - - - - -

EPS

-1.4 -1.4 -0.7 -0.9 1.4 1.1 - - - - - - -

EV (Enterprise Value)

160 M 126 M 91.8 M 21.8 M 3.39 M -15.4 M 330 M 196 M -28.7 M 31.2 M 16.2 M - -

EBITDA per Share

-1.39 -1.46 -0.84 -0.969 -3.69 -19.3 -34.1 -27.3 -65.4 - - - -

EV/EBITDA

-3.1 -1.4 -0.0 0.7 -6.2 -4.8 1.3 - - - -

PEG

0.85 0.32 0.65 0.03 -0.02 -0.01 0.31 -0.11 0.02 - - - -

P/B

7.0 3.8 2.4 1.7 1.1 0.4 6.2 3.1 0.7 - - - -

P/CF

-5.4 -6.5 -12.3 -3.6 -0.7 -0.4 -9.5 -8.5 -3.9 - - - -

ROE %

-41.71 -43.49 -10.00 -54.73 -59.83 -136.96 -81.54 -43.48 -22.93 - - - -

ROA %

-18.35 -24.85 -9.41 -48.06 -48.30 -112.83 -54.91 -35.00 -20.94 - - - -

ROCE %

-164.73 -94.71 -33.92 -53.96 -154.39 -101.74 -65.16 -37.91 -21.11 - - - -

Current Ratio

1.8 2.3 16.9 9.3 5.2 5.6 6.9 16.1 15.3 - - - -

DSO

- - - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios PDS Biotechnology Corporation

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.23 -0.3 - -0.35 -0.37 -0.32 - -0.26 -0.2 -0.32 - -0.24 -0.03 -0.14 - -0.21 -0.19 -0.39 - -1.1 -0.75 1.82 - -0.21 -0.17 -0.24 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

- -0.29 - - - -0.31 - -0.26 -0.25 -0.32 - -0.24 -0.22 -0.14 - -0.21 -0.19 -0.39 - -1.1 -0.81 -1.31 - -0.21 -0.17 -0.24 -0.52 -0.35 -0.43 -0.41 -0.38 -0.35 -0.32 -0.31 -0.31 -5 -2.92 -2.47 -2.38 -2.09 - - - - - - - - - - - - - -

ROE %

-144.08 -152.69 -103.42 -119.20 -90.66 -66.42 -42.26 -52.52 -47.00 -36.49 -23.57 -37.97 -42.11 -52.10 -39.88 -89.05 -123.83 -146.25 -24.11 17.71 108.70 175.31 118.61 2399.88 2339.97 2284.93 2222.02 -69.91 -63.87 -52.73 -43.48 -39.32 -35.54 -29.55 -22.93 -5.06 15.85 20.36 24.00 12.64 - - - - - - - - - - - - - -

ROA %

-67.07 -71.40 -51.18 -61.09 -52.03 -44.33 -34.19 -43.89 -43.68 -34.05 -21.44 -34.09 -37.03 -45.75 -35.03 -74.72 -101.77 -119.10 -19.47 -226.02 -392.88 -530.98 -585.77 -600.78 -406.41 -256.08 -54.91 -48.48 -46.00 -39.87 -35.00 -32.36 -30.21 -25.88 -20.94 -33.78 -46.86 -42.74 -39.41 -20.64 - - - - - - - - - - - - - -

ROCE %

-141.18 -152.22 -105.07 -120.54 -93.04 -67.70 -44.44 -54.70 -49.49 -42.69 -29.77 -44.17 -48.31 -52.13 -40.08 -90.07 -125.66 -151.35 -128.69 -86.93 4.83 74.69 118.45 2763.77 2704.52 2650.10 2587.86 -69.72 -63.75 -53.05 -44.26 -39.25 -34.66 -28.34 -21.64 0.04 19.76 23.81 27.22 12.79 - - - - - - - - - - - - - -

Current Ratio

2.0 2.2 1.8 1.8 2.0 2.5 2.3 2.7 12.2 11.8 16.9 18.4 17.6 8.2 8.2 8.2 8.2 8.2 5.2 - - 5.2 0.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency